| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
152,273,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
8,789,578 |
Avg
Vol: |
4,096,352 |
| 52
Week Range: |
$16.96 - $16.96 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Silverstein Jonathan |
officerTitle |
– • – |
2007-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
44,248 |
50,683 |
|
- |
|
| Whitcup Scott M |
officerTitle |
– • – |
2007-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
44,248 |
50,683 |
|
- |
|
| Mazzo David J |
officerTitle |
– • – |
2007-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
44,248 |
51,683 |
|
- |
|
| Austin Stephen G |
officerTitle |
– • – |
2007-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
44,248 |
53,183 |
|
- |
|
| Wheeler Craig A |
officerTitle |
– • – |
2007-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
44,248 |
50,683 |
|
- |
|
| Thomas Paul |
officerTitle |
– • – |
2007-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
44,248 |
50,683 |
|
- |
|
| Podlesak Dennis |
officerTitle |
– • – |
2007-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
44,248 |
51,683 |
|
- |
|
| Puntoriero Michael J |
Senior VP, Finance, CFO |
• – – |
2007-02-28 |
4 |
A |
$0.00 |
$10 |
D/D |
10,000 |
75,725 |
|
- |
|
| Sturgeon Martin J |
VP, Chief Accounting OfficerOf |
• – – |
2007-02-12 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
10,000 |
|
- |
|
| Puntoriero Michael J |
Senior VP, Finance, CFO |
• – – |
2006-12-13 |
4 |
A |
$0.00 |
$0 |
D/D |
57,600 |
65,725 |
|
- |
|
| Hopereese Theresa |
VP, Human Resources |
• – – |
2006-12-13 |
4 |
A |
$0.00 |
$0 |
D/D |
35,600 |
35,600 |
|
- |
|
| Brandt Eric |
President, CEO & Director |
• • – |
2006-12-13 |
4 |
A |
$0.00 |
$0 |
D/D |
137,200 |
358,907 |
|
- |
|
| Kaye Randall |
VP of Medical Affairs |
• – – |
2006-12-13 |
4 |
A |
$0.00 |
$0 |
D/D |
57,600 |
59,600 |
|
- |
|
| Katkin Keith |
Sr. V.P. of Sales & Marketing |
• – – |
2006-12-13 |
4 |
A |
$0.00 |
$0 |
D/D |
57,600 |
60,100 |
|
- |
|
| Sircar Jagadish C |
V.P. of Drug Discovery |
• – – |
2006-12-13 |
4 |
A |
$0.00 |
$0 |
D/D |
18,800 |
31,425 |
|
- |
|
| Hanson Gregory P |
VP, CAO & Secretary |
• – – |
2006-12-13 |
4 |
A |
$0.00 |
$0 |
D/D |
17,400 |
22,563 |
|
- |
|
| Brandt Eric |
President, CEO & Director |
• • – |
2006-12-06 |
4 |
D |
$2.90 |
$27,602 |
D/D |
(9,518) |
221,707 |
|
- |
|
| Brandt Eric |
President, CEO & Director |
• • – |
2006-09-06 |
4 |
D |
$6.73 |
$200,386 |
D/D |
(29,775) |
231,225 |
|
- |
|
| Silverstein Jonathan |
Director |
– • – |
2006-05-31 |
4/A |
D |
$9.79 |
$6,159,095 |
I/I |
(629,121) |
1,706,137 |
|
- |
|
| Orbimed Capital Ii Llc |
Director |
– • – |
2006-05-31 |
4/A |
D |
$9.79 |
$6,159,095 |
I/I |
(629,121) |
1,706,137 |
|
- |
|
| Silverstein Jonathan |
Director |
– • – |
2006-05-31 |
4 |
A |
$9.79 |
$3,407 |
D/D |
348 |
6,783 |
|
- |
|
| Silverstein Jonathan |
Director |
– • – |
2006-05-31 |
4 |
S |
$9.79 |
$6,159,095 |
I/I |
(629,121) |
1,706,137 |
|
- |
|
| Berg James E |
Vice President, Clinical |
• – – |
2006-05-30 |
4 |
OE |
$2.88 |
$108,000 |
D/D |
37,500 |
53,000 |
|
- |
|
| Puntoriero Michael J |
Senior VP, Finance, CFO |
• – – |
2006-05-25 |
4 |
B |
$9.00 |
$67,750 |
D/D |
7,500 |
8,125 |
2.74 |
- |
|
| Katkin Keith |
Sr. V.P. of Sales & Marketing |
• – – |
2006-05-25 |
4 |
B |
$8.98 |
$22,484 |
D/D |
2,500 |
2,500 |
2.74 |
- |
|
276 Records found
|
|
Page 10 of 12 |
|
|
